10-Q · May 14, 2026
The extracted filing text does not include the income statement, balance sheet, cash flow statement, or MD&A, so revenue, margin, EPS, liquidity, and cash-flow trends cannot be quantified. The principal disclosed issue…
Earnings analysis · 10-Q
Filed August 13, 2026 · Our reading of the company's report
The latest report
The filing provides limited operating detail in the extracted sections, with reported revenue of $293,000 and EPS of $0.12 but no disclosed margin, cash-flow, balance-sheet, or segment metrics. The dominant signal is…
The filing provides limited operating detail in the extracted sections, with reported revenue of $293,000 and EPS of $0.12 but no disclosed margin, cash-flow, balance-sheet, or segment metrics. The dominant signal is bearish: management identified substantial doubt about the Company’s ability to continue as a going concern and warned that financing may be unavailable on reasonable terms. Integration of the March 2026 Quantum Israel acquisition and the March 2025 Metagramm acquisition adds execution risk, although disclosure controls were considered effective as of June 30, 2026.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Management concluded that disclosure controls and procedures were effective as of June 30, 2026.
Management stated that substantial doubt exists about the Company’s ability to continue as a going concern, and the June 30, 2026 financial statements include a going-concern disclosure. The filing specifically warns this could prevent the Company from obtaining new financing on reasonable terms or at all.
The Company acquired Quantum Israel in March 2026 and Metagramm in March 2025. Management warned that integration difficulties, unanticipated costs or liabilities, and failure to achieve anticipated benefits could harm operating results, business, and financial condition.
The inclusion of Quantum Israel’s financial information beginning with the interim statements for the quarter ended March 31, 2026 requires implementation of internal controls over its reporting processes and procedures.
No quantitative guidance or outlook was provided in the extracted 10-Q; outlook may be addressed separately in the earnings release or call.
The extracted filing text does not include the income statement, balance sheet, cash flow statement, or MD&A, so revenue, margin, EPS, liquidity, and cash-flow trends cannot be quantified. The principal disclosed issue…
The provided extract contains no income statement, balance sheet, cash flow statement, segment results or MD&A financial data, so revenue, margins, EPS, liquidity and free cash flow trends cannot be assessed. The…
The extracted filing section does not provide the income statement, balance sheet, cash flow statement, segment data, or MD&A financial trends, so revenue, margins, EPS, liquidity balances, and free cash flow cannot be…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.